HS-173, a selective PI3K inhibitor, induces cell death in head and neck squamous cell carcinoma cell lines.

Elisabeth FokiIsabella StaniszLorenz KadletzUlana KotowskiRudolf SeemannRainer SchmidGregor Heiduschka

Published in: Wiener klinische Wochenschrift (2020)

The selective PI3K inhibitor HS-173 is a potent chemosensitizing and also radiosensitizing drug in treatment of HNSCC cell lines and could be an effective treatment in PI3K-mutated HNSCC.

Keyphrases

cell death
emergency department